Welcome to our dedicated page for Schrodinger SEC filings (Ticker: SDGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Schrödinger, Inc. (SDGR) SEC filings page on Stock Titan provides access to the company’s U.S. Securities and Exchange Commission disclosures, alongside AI-powered tools that help interpret key documents. As a Nasdaq-listed issuer, Schrödinger files current reports on Form 8-K, annual reports on Form 10-K and quarterly reports on Form 10-Q, among other documents, to provide transparency into its operations, governance and financial condition.
Recent Form 8-K filings illustrate the range of topics covered in SDGR’s regulatory reporting. The company has furnished press releases announcing quarterly financial results under Item 2.02, giving detail on software revenue, drug discovery revenue, software gross margin, operating expenses, cash position and non-GAAP measures. Other 8-K filings describe matters such as the submission of proposals to stockholders at the annual meeting, voting outcomes for director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm.
Schrödinger has also used Form 8-K to disclose executive compensation and separation arrangements under Item 5.02, including a separation and release of claims agreement with a former executive vice president and chief financial officer. These filings outline severance-related payments, equity vesting terms, COBRA-related benefits and other contractual provisions, providing insight into the company’s executive compensation framework.
On Stock Titan, users can review SDGR’s 10-K and 10-Q filings for detailed discussions of its software and drug discovery activities, risk factors, segment information and accounting policies. AI-powered summaries help explain lengthy filings by highlighting important sections, such as revenue breakdowns between software and drug discovery, non-GAAP reconciliations and disclosures related to collaborations and equity investments. The platform also surfaces Form 4 insider transaction reports, allowing users to track equity awards and share transactions by directors and officers.
With real-time updates from EDGAR and AI-generated overviews, the Schrödinger SEC filings page is intended to make it easier to navigate complex regulatory documents, compare periods and understand how SDGR’s computational platform, collaborations and therapeutics portfolio are reflected in its official disclosures.
Schrodinger, Inc. filed a Form 3 showing VP, Corporate Controller Therese Marie Abrams’ existing equity holdings. She directly holds 19,461 shares of common stock, which include 15,195 unvested restricted stock units that are scheduled to vest in tranches between
She also holds several stock option awards to buy common stock at exercise prices ranging from
Schrödinger, Inc. appointed Therese Abrams as its principal accounting officer effective March 8, 2026. She has been the company’s Vice President, Corporate Controller since July 2025 and previously held several senior finance and revenue roles at Schrödinger and other companies. She is a certified public accountant with a B.S. in Accounting from Oregon State University.
The company states there is no arrangement or understanding with any other person regarding her designation, no related-party transactions requiring disclosure, and no changes to her compensation in connection with the new role. Former Chief Accounting Officer and principal accounting officer Jenny Herman transitioned from that position on March 6, 2026 and will remain employed through April 10, 2026 to support the transition.
Schrodinger, Inc. Chief Accounting Officer Jenny Herman reported selling a total of 1,383 shares of common stock in two open-market transactions on March 5 and March 6, 2026, at weighted average prices around $12.84 per share. According to the filing, these sales were executed under a pre-established Rule 10b5-1 automatic sale instruction to cover withholding taxes triggered by vesting of restricted stock units, and were not discretionary trades. After these transactions, Herman directly holds 34,804 shares of common stock, which the filing notes includes 22,597 unvested restricted stock units.
Schrodinger, Inc. EVP & CFO Rachit Jain reported an open-market sale of 1,631 shares of common stock. The sale on March 5, 2026 was executed at a weighted average price of $12.896 per share, with individual trades ranging from $12.75 to $12.98.
According to the disclosure, this sale was made under a durable automatic sale instruction pursuant to Rule 10b5-1 and was a broker-assisted transaction to cover withholding tax obligations arising from the vesting of restricted stock units. The filing notes it was not a discretionary trade by the executive.
After this transaction, Jain directly holds 52,596 shares of Schrodinger common stock, which includes 47,997 unvested restricted stock units.
Schrodinger, Inc. executive Yvonne Tran, EVP, CLO & CPO, reported an open-market sale of common stock linked to tax withholding on vested restricted stock units. On March 5, 2026, she sold 1,094 shares at a weighted average price of $12.895 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 8, 2023. The sale was a broker-assisted transaction to satisfy withholding tax obligations and did not represent a discretionary trade. Following this transaction, she beneficially owns 52,683 shares of Schrodinger common stock, including 42,191 unvested RSUs.
Schrodinger, Inc. President & CEO Ramy Farid reported an automatic tax-related stock sale. On this Form 4, he sold 3,661 shares of common stock in an open-market transaction under a pre-arranged Rule 10b5-1 trading plan adopted on March 8, 2023, to cover withholding taxes from vesting RSUs. The weighted average sale price was $12.906 per share, with individual trades ranging from $12.73 to $13.00. After this transaction, he beneficially owned 330,824 shares of Schrodinger common stock, which includes 132,634 unvested restricted stock units.
Schrodinger, Inc. officer Karen Akinsanya reported an open-market sale of 1,366 shares of common stock at a weighted average price of $12.903 per share. According to the filing, this Rule 10b5-1 transaction was a broker-assisted sale solely to cover withholding taxes on vesting RSUs and was not a discretionary trade. After the sale, she directly owned 69,956 shares, including 63,545 unvested restricted stock units.
Schrodinger, Inc. executive Kenneth Patrick Lorton, EVP, CTO & COO, Software, reported an open-market sale of 1,222 shares of common stock on March 5, 2026. The shares were sold under a pre-arranged Rule 10b5-1 automatic plan to cover withholding taxes from restricted stock unit vesting and were executed as a broker-assisted, non-discretionary transaction at a weighted average price of $12.898 per share. After this sale, Lorton directly held 89,241 shares of common stock, including 49,230 unvested RSUs.
Schrodinger, Inc. officer Robert Lorne Abel reported an open-market sale of 1,300 shares of common stock on March 4, 2026 at $12.81 per share. After this transaction, he directly owned 55,897 shares.
According to the disclosure, the sale was executed under a Rule 10b5-1 trading plan adopted on August 25, 2025 and was a broker-assisted sale to cover withholding tax due upon the vesting of restricted stock units. The filing notes that this did not represent a discretionary trade by the officer and that his holdings include 49,824 unvested RSUs.
Jenny Herman reported a proposed sale of 608 shares of common stock. The sale is identified as Restricted Stock Vesting and dated